 |
|
 |
Companies |
|
|
Smith & Nephew Medical Device Company Intelligence Report
Publication Date April 2007
Publisher Espicom
Product Type Report
Pages 94
ISBN Number not applicable
Product Code ESP555
|
|
|
Summary
On 12th July 2006, it was announced that Bayer's public takeover offer for Schering AG had been completed. With estimated annual sales of nearly EUR 15 billion (calculated on 2005 sales), this acquisition creates a global healthcare company that will rank among the top 12 in the world.
Schering is a research-based pharmaceutical company, headquartered in Germany, that has been engaged in the pharmaceuticals business for over 130 years. Schering has more than 140 subsidiaries and affiliates worldwide and employs over 25,000 people. It currently ranks 17th among researched-based pharmaceutical companies in terms of pharma sales. It annually invests about 19 per cent of its total sales in research and development, ranking 18th compared to other pharmaceutical companies.
Schering is active in four therapeutic areas: fertility control and hormone therapy; oncology; central nervous system diseases such as multiple sclerosis and Parkinson's disease; and diagnostic imaging.
Current growth drivers
Betaferon/Betaseron, which was the first product to be approved and launched as a disease-modifying treatment for multiple sclerosis, will remain as Schering's main growth driver until the oral contraceptive Yasmin begins to take over in 2008. The success of Yasmin is a key factor that will help drive Schering's future growth.
Key late-phase products reaching the market place
Vasovist, an injectable intravascular contrast agent, received EU approval in October 2005 and it was launched in the second quarter of 2006. Vasovist is expected to be one of the future growth drivers in the field of diagnostic imaging.
Pharmaceutical company intelligence reports provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to a complete analysis of its latest full fiscal year and an outlook for the future. A section on company strategy covers mergers, acquisitions and divestitures, key agreements, products and R&D. An overview of key products and R&D is followed by a comprehensive review of the company's product portfolio and research and development pipeline by therapeutic area. In addition, supplementary appendices provide more in-depth information on financials, agreements and corporate events.
|
Content
- Executive Summary
- Overview
- Recent Key Events
- Financial Results
- Revenue by Division, 2004-2006 (US$ million)
- Fig.1: Percentage of Revenue by Division, 2006
- Strategic Focus
- Reconstruction
- Plus Orthopedics Holding Acquisition
- Trauma & Clinical Therapies
- Endoscopy
- Advanced Wound Management
- Product Portfolio And R&d
- Fig.2: Global Orthopaedic Market Shares, 2006
- Reconstruction Products
- Operating Results - Reconstruction Division, 2005-2006 (US$ million)
- Fig.3: Reconstruction Division - Sales by Product Type, 2006
- Fig.4: Reconstruction Division - Sales by Region, 2006
- Market Dynamics
- Fig.5: Global Reconstruction Market Shares, 2006
- Fig.6: Global Reconstruction Market by Product, 2006
- Key Products and Technologies
- Recent Product Approvals
- Computer-Assisted Surgery
- AchieveCAS
- BrainLAB Products
- iON IntraOperative Navigation System
- Knee Products
- Journey Deuce Knee
- Journey Bi-Cruciate Stabilized Knee System
- Legion Revision Knee System
- Genesis II Knee System
- Profix Total Knee System
- Hip Implant Products
- Birmingham Hip Resurfacing System
- BHR Survivorship Results*
- Emperion Modular Hip System
- Anthology Hip Stem
- Synergy Hip System
- Spectron Total Hip System
- Reflection Ceramic Acetabular System
- Shoulder Systems
- Cements and Accessories
- Trauma And Clinical Therapies Division
- Operating Results - Trauma & Clinical Therapies, 2005-2006 (US$ million)
- Fig.7: Trauma & Clinical Therapies - Sales by Product, 2006
- Fig.8: Trauma & Clinical Therapies - Sales by Region, 2006
- Fig.9: Trauma & Clinical Therapies Market, US$4.6 billion, 2006*
- Recent Product Approvals
- Trauma Products
- Fig.10: Global Fixation Market, 2006*
- Internal Fixation Products
- TriGen Intramedullary Nail System
- Peri-Loc Periarticular Locked Plating System
- Intramedullary Hip Screw (IMHS)
- IMHS CP
- Asian IMHS
- External Fixation
- JET-X Unilateral Fixator
- Taylor Spatial Frame Fixator
- Ilizarov External Fixator
- Osteobiologics
- Clinical Therapies
- Joint Fluid Therapy Products
- Durolane
- Supartz Joint Fluid Therapy
- Bone Repair Stimulation Market
- Exogen Bone Healing System
- Spine Products
- Intradiscal ElectroThermal (IDET) Procedure and the SpineCATH Catheter
- Controlled Disc Stimulation (CDS) System
- Electrothermal 20S Spine System
- Acutherm Decompression Catheter
- Endoscopy
- Operating Results - Endoscopy Division, 2005-2006 (US$ million)
- Fig.11: Endoscopy Division - Sales by Region, 2006
- Fig.12: Endoscopy Division - Sales by Product Type, 2006
- Recent Product Approvals
- Key Arthroscopy Products
- Fig.13: Global Arthroscopy Market (US$2 billion), 2006*
- Acufex Hand-Held Instrumentation
- Dyonics Arthropak Procedure Kits
- Bioraptor Suture Anchor
- Hip Products
- Lateral Hip Distractor
- Hip Positioning System
- Knee Products
- OsteoBiologics' TruFit Products
- Calaxo Osteoconductive Interference Screw
- GTS System
- FasT-Fix Meniscal Repair System
- Shoulder Arthroscopy
- Kinsa Suture Anchor
- Accu-Pass Suture Shuttle
- Radiofrequency Devices
- S&N ElectroThermal Arthroscopy System
- Dyonics Series 9000 ElectroBlade Resector
- Dyonics Powered Instruments
- Access/Fluid Management Systems
- Vascular Products
- TriVex System
- VIsualisation/Image Management
- Digital OR and the Condor Control System
- 660HD Image Management System
- SV420 Camera Series
- Advanced Wound Management
- Operating Results - Advanced Wound Management, 2005-2006 (US$ million)
- Fig.14: Advanced Wound Management Sales by Region, 2006
- Fig.15: Advanced Wound Management Sales by Product, 2006
- Wound Care Market
- Fig.16: Global Wound Care Market, 2005-2006 (US$ billion)*
- Wound Care Market by Product, 2005-2011 (US$ million)*
- Leading Advanced Wound Care Manufacturers' Sales and Market Shares, 2006
- Fig.17: Global Advanced Wound Care Market (US$4.1 billion), 2006*
- Key Products
- Recent Product Approvals
- Biobrane Biosynthetic Wound Dressing
- VersaJet Hydrosurgery System
- Allevyn Hydrocellular (Foam) Dressings
- Allevyn Non-Adhesive
- Allevyn Adhesive and Allevyn Sacrum
- Iodosorb/Iodoflex Infection Management Products
- Cadesorb PH-Modulating Ointment
- Acticoat Antimicrobial Dressings
- Melolin Low Adherent Dressings
- IV3000 IV Dressings
- Primapore
- Catrix Wound Dressing
- Research And Development
- Research Establishments
- S&N Research Centre
- Research Projects
- Cross-Business Research Programmes
- Biomaterials
- Cell-based Therapies
- Orthopaedics Research Programme
- Endoscopy Research Programmes
- Advanced Wound Management
- Research Agreements
- Q-Med
- Alexandria Research Technologies
- Helix BioMedix
- GE Healthcare
- International Activities
- Revenue by Location of Customer, 2004-2006 (US$ million)
- Revenue by Geographic Origin, 2004-2006 (US$ million)
- Assets by Geographic Region, 2004-2006 (US$ million)
- Fig.18: Percentage of Revenue by Location of Customer, 2006
- Fig.19: Percentage of Revenue by Geographic Origin, 2006*
- Fig.20: Percentage of Assets by Geographic Region, 2006*
- Fig.21: S&N and Plus Orthopedics - Combined Pro Forma Sales by Region, 2006*
- United Kingdom
- United States
- Endoscopy
- Reconstruction and Trauma & Clinical Therapies
- Wound Management
- Continental Europe
- Spain
- Switzerland
- ASIA
- Japan
- Major Manufacturing Locations
- Appendices
- Appendix 1 - Financial Indicators
- Appendix 2 - Key Corporate Events
- Appendix 3 - Mergers And Acquisitions
- Key Mergers & Acquisitions
- Plus Orthopedics Holding
- OsteoBiologics
- Leading Medical
- Midland Medical Technologies
- Reed Medical Designs
- Versajet Surgical Debridement Product
- Advanced Tissue Sciences' Assets
- Oratec Interventions
- Instrument Makar
- Westaim Biomedical's Burns Dressing Business
- Beiersdorf's Advanced Woundcare Business
- Orthopaedic Biosystems
- 3M's Orthopaedic Implant Business
- Exogen
- Exu-Dry
- Perstorp Wound Care Products
- Medizintechnik Konrad Ludi
- Acufex Microsurgical's American Home Products
- Basel SpA
- Appendix 4 - Divestitures
- Tissue Engineering Products
- BSN Medical
- AbilityOne Products
- Rehabilitation Business
- ENT Business
- Female Hygiene and Toiletries Division
- First Aid Dressings Business
- Bracing and Support Systems Business
- Spinal Product Line
- Perry
- Southalls Hygiene Washroom Servicing Operations
- Ditropan Incontinence Drug
- Ioptex Research
- Nivea Toiletries
- SoloPak
- Equipment and Plastics Divisions
- Appendix 5 - Agreements
- Key Agreements
- Covalon Technologies
- UDL Laboratories
- Movianto Deutschland
- Nexa Orthopedics
- Lescarden
- Q-Med
- Derma Sciences
- ArthroCare
- PhDx Systems
- Orthocrat
- Orthosoft
- Tenet Medical Engineering
- Osteotech
- Finsbury Orthopaedics
- Lumitex
- BrainLAB
- Medtronic
- IsoTis
- Nucryst Pharmaceuticals (Westaim Biomedical)
- BTG
- Seikagaku
- Kurgan All Union Scientific Centre for Restorative Traumatology and Orthopaedics
- Advanced Medical Solutions
- Supply Agreements
- Novation
- Kaiser Permanente
- Amerinet
- Termination of Agreement
- HealthPoint
- Appendix 6 - Litigation
- Synthes
- US Subpoenas
- Arthrotek
- Arthronet GmbH & Co KG
- ArthroCare
- Macrotextured Oxinium Femoral Knee Components
- Recent Key Events
- Revenue by Division, 2004-2006 (US$ million)
- Operating Results - Reconstruction Division, 2005-2006 (US$ million)
- Recent Product Approvals
- BHR Survivorship Results*
- Operating Results - Trauma & Clinical Therapies, 2005-2006 (US$ million)
- Recent Product Approvals
- Operating Results - Endoscopy Division, 2005-2006 (US$ million)
- Recent Product Approvals
- Operating Results - Advanced Wound Management, 2005-2006 (US$ million)
- Wound Care Market by Product, 2005-2011 (US$ million)*
- Leading Advanced Wound Care Manufacturers' Sales and Market Shares, 2006
- Recent Product Approvals
- Revenue by Location of Customer, 2004-2006 (US$ million)
- Revenue by Geographic Origin, 2004-2006 (US$ million)
- Assets by Geographic Region, 2004-2006 (US$ million)
- Major Manufacturing Locations
- Key Mergers & Acquisitions
- Key Agreements
- Fig.1: Percentage of Revenue by Division, 2006
- Fig.2: Global Orthopaedic Market Shares, 2006
- Fig.3: Reconstruction Division - Sales by Product Type, 2006
- Fig.4: Reconstruction Division - Sales by Region, 2006
- Fig.5: Global Reconstruction Market Shares, 2006
- Fig.6: Global Reconstruction Market by Product, 2006
- Fig.7: Trauma & Clinical Therapies - Sales by Product, 2006
- Fig.8: Trauma & Clinical Therapies - Sales by Region, 2006
- Fig.9: Trauma & Clinical Therapies Market, US$4.6 billion, 2006*
- Fig.10: Global Fixation Market, 2006*
- Fig.11: Endoscopy Division - Sales by Region, 2006
- Fig.12: Endoscopy Division - Sales by Product Type, 2006
- Fig.13: Global Arthroscopy Market (US$2 billion), 2006*
- Fig.14: Advanced Wound Management Sales by Region, 2006
- Fig.15: Advanced Wound Management Sales by Product, 2006
- Fig.16: Global Wound Care Market, 2005-2006 (US$ billion)*
- Fig.17: Global Advanced Wound Care Market (US$4.1 billion), 2006*
- Fig.18: Percentage of Revenue by Location of Customer, 2006
- Fig.19: Percentage of Revenue by Geographic Origin, 2006*
- Fig.20: Percentage of Assets by Geographic Region, 2006*
- Fig.21: S&N and Plus Orthopedics - Combined Pro Forma Sales by Region, 2006*
|
|
|
